Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3111-3121
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3111
Table 1 Comparison of clinical characteristics between patients with early hepatocellular carcinoma and patients with typical hepatocellular carcinoma
eHCCtHCCP value
Number of nodules50187
Follow-up days1, median (range)1213 (216-2137)1116 (181-2328)0.1582
Age, mean (range)69.8 (50-87)71.6 (54-84)0.2002
Child-Pugh score, A/B49/1179/80.0992
Tumor diameter in mm, mean (range)15.8 (10-23)15.6 (6-30)0.1542
Sex, male/female35/15125/580.8343
Etiology, HCV/HBV/alcohol/others441/4/6/1139/29/8/110.1985
Table 2 Evaluation of thinnest ablative margins for early hepatocellular carcinoma (n = 50) and typical hepatocellular carcinoma (n = 187) classified into two groups according to contrast-enhanced ultrasonography
eHCCtHCCP value1
AM 0 to < 5 mm80% (40/50)85.5% (160/187)NS
AM ≥ 5 mm20% (10/50)14.4% (27/187)NS
Table 3 Frequency of local tumor progression classified into two groups according to ablative margin for early hepatocellular carcinoma (n = 50) and typical hepatocellular carcinoma (n = 187)
AM 0 to < 5 mmAM ≥ 5 mm
Local tumor progression
eHCC2.5% (1/40)0% (0/10)
tHCC27.5% (44/160)7.4% (2/27)
P value10.01NS